FILE:CERN/CERN-8K-20040421165156.txt.gz
EVENTS:	Financial statements and exhibits	Regulation FD Disclosure
TEXT:
ITEM: Financial statements and exhibits
ITEM: Regulation FD Disclosure
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) April 21, 2004 Cerner Corporation ------------------------------------------ (Exact name of Registrant as Specified in its Charter) Delaware --------------------------- (State or other jurisdiction of Incorporation) 0-15386 43-1196944 - ------------------------ ------------------------------------ (Commission File Number) (I.R.S. Employer Identification No.) 2800 Rockcreek Parkway, North Kansas City, Missouri 64117 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) (816) 221-1024 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code) Not Applicable - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report)
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. The following exhibit is furnished herewith. 99.1 Press Release issued April 21, 2004. Item 9. Regulation FD Disclosure Cerner Corporation is furnishing herewith as Exhibit 99.1, the Press Release issued by the Company on April 21, 2004, which announces the Company's financial results for the three months ended April 3, 2004. This Press Release is being furnished under this Item 9 in accordance with SEC Release No. 33-8216 dated March 27, 2003. To supplement our consolidated financial statements presented in accordance with GAAP, the Company uses non-GAAP measures of operating results, net income and earnings per share, which are adjusted from results based on GAAP to exclude certain expense items. The Company also discloses certain non-GAAP financial measures, such as booking revenue, revenue backlog and free cash flow. These non-GAAP measures are provided to enhance the user's overall understanding of our financial performance. These measurements are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, unless the registrant expressly states otherwise. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CERNER CORPORATION Date: April 21, 2004 By: /s/ Marc G. Naughton -------------------------------------------- Marc G. Naughton, Senior Vice President, Treasurer and Chief Financial Officer
EXHIBIT INDEX Exhibit Number Description Page - ------- ------------ ---- 99.1 Press Release issued April 21, 2004, furnished pursuant to Item 9 of this Form 8-K.

Exhibit 99.1 Cerner Delivers Strong New Business Bookings; Margin Expansion and Cash Flow also Strong KANSAS CITY, Mo.--(BUSINESS WIRE)--April 21, 2004--Cerner Corporation (NASDAQ:CERN) today announced results for the 2004 first quarter ended April 3, 2004. Diluted earnings per share were $0.38, compared to $0.15 in the first quarter of 2003. The first quarter of 2004 included a gain on the sale of Zynx Health Incorporated that increased earnings per share by $0.05. Analysts' consensus estimates for first quarter earnings per share were $0.32. First quarter revenues increased 10 percent to $218.7 million compared to $198.2 million in the year-ago quarter. Net earnings in the quarter were $14.1 million, compared to $5.6 million in the first quarter of 2003. The gain on the sale of Zynx Health increased first quarter of 2004 net earnings by $1.8 million ($3 million, net of $1.2 million of tax). The Company continued to experience strong demand for its solutions with $216.4 million of new business bookings, up 43 percent compared to $151.1 million in the first quarter of 2003. The Company generated strong operating cash flow of $30.7 million in the first quarter driven by strong cash collections and a significant number of Cerner Millennium(TM) implementations. Other First Quarter Highlights: -- Operating margin of 10.3 percent, an increase of 460 basis points compared to the first quarter of 2003. -- Strong cash collections of $218 million. -- Days Sales Outstanding (DSOs) of 108 days, which is 7 days lower than a year ago. -- Total revenue backlog of $1.32 billion, up 29 percent over the year-ago quarter. This is comprised of $1.0 billion of contract backlog and $318.5 million of support and maintenance backlog. -- 187 Cerner Millennium solutions were implemented during the quarter. Cerner has now turned on more than 2,800 Cerner Millennium solutions at over 600 client facilities worldwide. -- Computerized Physician Order Entry was brought live at 54 locations, bringing the total to more than 250. "We are very pleased with the progress Cerner made on many fronts in the first quarter," said Neal Patterson, Cerner's co-founder, Chairman and Chief Executive Officer. "We continued to create quality revenue growth along with strong margin expansion and cash flow generation." "Our high level of new business bookings reflects our continued leadership in the important healthcare information technology industry," added Patterson. "We believe there remains significant demand for healthcare information technology, and we feel good about our ability to benefit from this demand because of our proven solutions and unmatched depth and breadth of offerings." Future Period Guidance Cerner expects earnings per share in the second quarter of 2004 to be between $0.35 and $0.37. The Company expects revenue in the second quarter to be approximately $225 million to $230 million. Cerner expects bookings revenue in the second quarter to be between $200 million and $220 million. For 2004, the Company expects earnings per share between $1.63 and $1.67 (not including the $0.05 gain from the sale of Zynx Health), which is up from previous guidance of $1.60 to $1.65. Cerner expects revenue for 2004 to be at the upper end of its existing guidance range of $920 million to $940 million. The Company also reiterated its cash flow guidance for 2004, indicating that it expects to generate between $120 million and $140 million of operating cash flow. Based on these estimates, the Company expects to generate positive free cash flow, defined as operating cash flow less capital expenditures and capitalized software, in 2004. Earnings Conference Call Cerner will host an earnings conference call to provide additional detail at 3:30 p.m. CT on April 21, 2004. The dial-in number for the call is (617) 786-2963 and the replay number is (617) 801-6888 (Pass code: 50856446). The call will also be Web cast and available both live and archived on Cerner's Web site at www.cerner.com in the Investors' section under News and Events. Please access the site fifteen minutes early to register and to download and install any necessary audio software. For those who cannot listen to the live broadcast, replays will be made available shortly after the call and will run for two weeks. A copy of the script used during the call will also be available at www.cerner.com in the Investors' section under News and Events. Cerner Corp. is taking the paper chart out of healthcare, eliminating error, variance and waste in the care process. With more than 1,500 clients worldwide, Cerner is the leading supplier of healthcare information technology. The following are trademarks of Cerner: Cerner, Cerner Millennium, and Cerner's logo. (Nasdaq:CERN), www.cerner.com. This release may contain forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company's performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words "believe", "feel", "expects", "guidance" or variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: quarterly operating results may vary, stock price may be volatile, market risk of investments, potential impairment of goodwill, changes in the healthcare industry, significant competition, the Company's proprietary technology may be subjected to infringement claims or may be infringed upon, regulation of the Company's software by the U.S. Food and Drug Administration or other government regulation, the possibility of product-related liabilities, possible system errors or failures or defects in the performance of the Company's software, risks associated with the Company's global operation and the recruitment and retention of key personnel. Additional discussion of these and other factors affecting the Company's business is contained in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time. Cerner Corporation Consolidated Statements of Income Three Months Three Months Ended Ended (In thousands, except per share April 3, 2004(1) March 29, 2003 data) ---------------- --------------- Revenue System sales $ 84,512 78,594 Support, maintenance and services 127,069 112,932 Reimbursed travel 7,146 6,665 ------------------- --------------- Total revenue 218,727 198,191 Margin System sales 57,779 50,389 Support and maintenance 114,275 99,550 ------------------- --------------- Total margin 172,054 149,939 ------------------- --------------- Operating expenses Sales and client service 92,842 88,091 Software development 42,554 37,458 General and administrative 14,145 13,142 ------------------- --------------- Total operating expenses 149,541 138,691 ------------------- --------------- Operating earnings 22,513 11,248 Interest income 442 409 Interest expense (2,557) (2,255) Other income 3,014 16 ------------------- --------------- Non-operating income (expense), net 899 (1,830) Earnings before income taxes 23,412 9,418 Income taxes (9,283) (3,825) ------------------- --------------- Net earnings $ 14,129 5,593 =================== =============== Basic earnings per share $ 0.40 0.16 =================== =============== Basic weighted average shares outstanding 35,661 35,559 Diluted earnings per share $ 0.38 0.15 =================== =============== Diluted weighted average shares outstanding 37,222 36,710 Note 1: Includes a gain on the sale of Zynx Health Incorporated. The impact of this gain is a $1.8 million increase, net of $1.2 million tax expense, in net earnings and an increase to diluted earnings per share of $.05 for 2004. Cerner Corporation Consolidated Balance Sheets (In thousands) April 3, January 3, 2004 2004 --------- ---------- Assets Cash and cash equivalents $ 141,528 121,839 Receivables 259,065 256,574 Inventory 11,885 12,434 Prepaid expenses and other 33,379 38,132 ------------- ---------- Total current assets 445,857 428,979 Property and equipment, net 211,408 204,953 Software development costs, net 145,633 141,090 Goodwill, net 52,855 51,573 Intangible assets, net 22,375 24,036 Investments, net 664 692 Other assets 5,447 8,017 ------------- ---------- Total assets $ 884,239 859,340 ============= ========== Liabilities Accounts payable $ 14,385 20,753 Current installments of long-term debt 23,532 21,162 Deferred revenue 63,241 64,879 Deferred income taxes 15,555 15,586 Accrued payroll and tax withholdings 46,920 45,004 Other accrued expenses 12,629 10,095 ------------- ---------- Total current liabilities 176,262 177,479 ------------- ---------- Long-term debt, net 130,534 124,570 Deferred income taxes 61,158 59,500 Deferred revenue 1,945 1,945 ------------- ---------- Total liabilities 369,899 363,494 ------------- ---------- Minority owners' equity interest in subsidiary 1,166 1,166 Stockholders' Equity Common stock 374 371 Additional paid-in capital 241,432 236,969 Retained earnings 293,492 279,363 Treasury stock, at cost (1,502,999 shares in 2003 and 2002) (26,793) (26,793) Foreign currency translation adjustment 4,669 4,770 ------------- ---------- Total stockholders' equity 513,174 494,680 Total liabilities and equity $ 884,239 859,340 ============= ========== CONTACT: Cerner Corporation Investors: Allan Kells, 816-201-2445 akells@cerner.com or Media: Justin Scott, 816-201-6438 jscott@cerner.com


